F. Weber

All filings by F. Weber on record concern Vivoryon Therapeutics N.V. Over a trading history stretching from 15 September 2023 to 17 April 2026, the count stands at 10 filings.

In open-market terms, that means 9 purchases worth €528k on one side and 1 sale on the other. No amount is published for 6 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2026 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €135k and half below. On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

Most recently, on 17 April 2026, the filings show an open-market purchase in Vivoryon Therapeutics N.V. Every figure here comes from the filings published by AFM and describes the past, not future prices; it is not investment advice.